MAPT and Alzheimer disease: Ten MDAAs, mulberrofuran J (1), mulberrofuran C (6), inethermulberrofuran C (20), mulberrofuran G (31), mulberrofuran K (40), albafuran C (50), isomulberrofuran G (57), kuwanol A (64), kuwanon G (92), and kuwanon H (93), were systematically screened for their anti-Alzheimer's disease (anti-AD) properties on different targets such as tau aggregation, Aβ self-aggregation, and ChEs.